XML 48 R23.htm IDEA: XBRL DOCUMENT
v3.25.1

Concentration of Risk | 12 Months Ended
--- | ---
Jan. 26, 2025
Risks and Uncertainties [Abstract] |
Concentration of Risk | Concentration of Risk The following significant customers accounted for at least 10% of the Company's net sales in one or more of the periods indicated:
| Fiscal Year Ended
(percentage of net sales) (1) | January 26, 2025 |  | January 28, 2024 |  | January 29, 2023
Customer A | 10% |  | * |  | 16%
Customer B | 13% |  | 10% |  | 13%
Customer C | * |  | * |  | 11%
(1) In each period with an asterisk, the customer represented less than 10% of the Company's net sales. The following table shows the customers that have an outstanding receivable balance that represents at least 10% of the Company's total net receivables as of one or more of the dates indicated:
(percentage of net receivables) (1) | January 26, 2025 |  | January 28, 2024
Customer D | 12% |  | *
Customer B | 12% |  | 15%
(1) In each period with an asterisk, the customer represented less than 10% of the Company's net receivables. For fiscal years 2025, 2024 and 2023, authorized distributors accounted for approximately 72%, 66% and 85%, respectively, of the Company’s net sales. Generally, the Company does not have long-term contracts with its distributors and most can terminate their agreement with little or no notice. For fiscal year 2025, the Company's largest distributors were based in Asia. Outside Subcontractors and Suppliers The Company relies on a limited number of third-party subcontractors and suppliers for the supply of silicon wafers, chipsets and other electronic components, and for product manufacturing, packaging, testing and certain other tasks. Disruption or termination of supply sources or subcontractors have delayed and could in the future delay shipments and could have a material adverse effect on the Company. Although there are generally alternate sources for these materials and services, qualification of the alternate sources could cause delays sufficient to have a material adverse effect on the Company. A significant amount of the Company’s third-party subcontractors and suppliers, including third-party foundries that supply silicon wafers, are located in the U.S., China and Taiwan. A significant amount of the Company’s assembly and test operations are conducted by third-party contractors in Canada, China, Malaysia, Taiwan and Vietnam.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration